Endocrine system 1. Describe the adrenal gland: its structure, hormones (cortex vs medulla), and related diseases. 2. Explain the pituitary gland: anatomical divisions, hormones, and disorders. 3. Describe the thyroid gland: structure, hormone synthesis, and common diseases. 4. Explain the parathyroid glands: structure, hormones, and disorders. 5. Describe the pancreas (endocrine part): islets, hormones, and diseases. 6. Explain the hypothalamus: structure, releasing hormones, and dysfunctions. 7. Describe the pineal gland: structure, hormone, and physiological role. 8. Explain the ovaries: structure, hormones, and endocrine disorders. 9. Describe the testes: structure, hormones, and dysfunctions. 10. Explain the thymus: structure, hormones, and role in immunity. 11. Describe the adrenal cortex separately: zones, hormones, and diseases. 12. Explain the adrenal medulla: structure, catecholamines, and related tumors. 13. Describe the anterior pituitary: hormones, regulation, and disorders. 14. Explain the posterior pituitary: hormones, origin, and clinical conditions. 15. Describe thyroid hormone synthesis: steps, regulation, and pathological changes. 16. Explain calcium homeostasis: hormones involved and related diseases. 17. Describe glucose regulation: hormones, mechanisms, and disorders. Give me best answer for viva exam and for better explanation and understanding
| Zone | % of Cortex | Hormone | Mnemonic |
|---|---|---|---|
| Zona Glomerulosa | 15% | Mineralocorticoids (Aldosterone) | Salt |
| Zona Fasciculata | 75% | Glucocorticoids (Cortisol) | Sugar |
| Zona Reticularis | 10% | Sex steroids (DHEA, androgens) | Sex |
| Disease | Cause | Key Features |
|---|---|---|
| Cushing Syndrome | Excess cortisol | Moon face, buffalo hump, central obesity, striae, hypertension, hyperglycemia |
| Cushing Disease | Pituitary ACTH-secreting adenoma (70% of endogenous cases) | Same as above + bilateral adrenal hyperplasia |
| Conn Syndrome (Primary Hyperaldosteronism) | Adrenal adenoma secreting aldosterone | Hypertension, hypokalemia, metabolic alkalosis |
| Addison Disease | Adrenocortical insufficiency | Weakness, hyperpigmentation, hypotension, hyponatremia, hyperkalemia |
| Adrenogenital Syndrome | Excess androgens (CAH) | Virilization, ambiguous genitalia (21-hydroxylase deficiency most common) |
| Disease | Feature |
|---|---|
| Pheochromocytoma | Catecholamine-secreting tumor → episodic hypertension, headache, palpitations, sweating (Rule of 10s) |
| Neuroblastoma | Malignant tumor of children from neural crest cells |
| Division | Also Called | Origin |
|---|---|---|
| Anterior pituitary | Adenohypophysis | Rathke's pouch (epithelial) |
| Posterior pituitary | Neurohypophysis | Neural tissue (hypothalamus) |
| Pars intermedia | — | Between the two (rudimentary in adults) |
| Hormone | Cell Type | Target | Action |
|---|---|---|---|
| GH (Growth Hormone) | Somatotrophs | Liver/tissues | Growth, IGF-1 release, protein synthesis |
| ACTH (Corticotropin) | Corticotrophs | Adrenal cortex | Stimulates cortisol |
| TSH (Thyrotropin) | Thyrotrophs | Thyroid | Stimulates T3/T4 |
| FSH | Gonadotrophs | Gonads | Follicle development, spermatogenesis |
| LH | Gonadotrophs | Gonads | Ovulation, testosterone production |
| Prolactin | Lactotrophs | Breast | Milk production |
| Disorder | Mechanism | Features |
|---|---|---|
| Acromegaly | GH excess in adults | Enlarged hands, feet, jaw, coarse features, organomegaly |
| Gigantism | GH excess before epiphyseal fusion | Tall stature |
| Hyperprolactinemia | Prolactinoma (most common pituitary tumor) | Galactorrhea, amenorrhea, infertility |
| Craniopharyngioma | Rathke's pouch remnant | Calcification, visual field defects, bitemporal hemianopia |
| Diabetes Insipidus | ADH deficiency (central) or resistance (nephrogenic) | Polyuria, polydipsia, dilute urine |
| SIADH | ADH excess | Hyponatremia, concentrated urine |
| Sheehan Syndrome | Postpartum pituitary necrosis | Panhypopituitarism |
| Empty Sella Syndrome | Enlarged sella with CSF | Headache, sometimes hypopituitarism |
| Disease | Cause | Features |
|---|---|---|
| Graves' Disease | Autoimmune: TSI antibodies stimulate TSH-R | Hyperthyroidism, diffuse goiter, exophthalmos, pretibial myxedema |
| Hashimoto Thyroiditis | Autoimmune destruction (anti-TPO, anti-thyroglobulin) | Most common hypothyroid cause; Hürthle cell change, lymphocytic infiltrate |
| Simple/Non-toxic Goiter | Iodine deficiency → ↑TSH → gland hypertrophy | Enlarged gland, euthyroid |
| Toxic Multinodular Goiter | Autonomously functioning nodules | Hyperthyroidism, irregular enlarged gland |
| Papillary Carcinoma | Most common thyroid cancer | Orphan Annie nuclei, psammoma bodies, good prognosis |
| Follicular Carcinoma | Invasion of capsule/vessels | Hematogenous spread to bone/lung |
| Medullary Carcinoma | C-cell tumor → calcitonin | Amyloid deposits, associated with MEN-2 |
| Anaplastic Carcinoma | Undifferentiated | Most aggressive, poor prognosis |
| Hypothyroidism | Various | Myxedema, fatigue, cold intolerance, bradycardia |
| Disorder | Cause | Features |
|---|---|---|
| Primary Hyperparathyroidism | Adenoma (80%), hyperplasia, carcinoma | Hypercalcemia, hypophosphatemia, "bones, stones, groans, moans" (bone pain, renal stones, GI upset, psychiatric) |
| Secondary Hyperparathyroidism | Chronic renal failure → ↓Ca²⁺ → ↑PTH | Renal osteodystrophy, hyperphosphatemia |
| Tertiary Hyperparathyroidism | Autonomous PTH secretion despite CRF correction | Hypercalcemia despite treating secondary cause |
| Hypoparathyroidism | Post-surgical, autoimmune, DiGeorge syndrome | Hypocalcemia, tetany, Chvostek's sign, Trousseau's sign, prolonged QT |
| Pseudohypoparathyroidism | End-organ resistance to PTH (Albright Hereditary Osteodystrophy) | Hypocalcemia with ↑PTH |
| Cell | % | Hormone | Action |
|---|---|---|---|
| Beta (B) | 60% | Insulin + Amylin | ↓Blood glucose (anabolic) |
| Alpha (A) | 25% | Glucagon | ↑Blood glucose (catabolic) |
| Delta (D) | 10% | Somatostatin | Inhibits insulin & glucagon |
| PP (F) | <5% | Pancreatic polypeptide | Inhibits exocrine pancreas |
| Disease | Mechanism | Features |
|---|---|---|
| Type 1 DM | Autoimmune destruction of beta cells | Absolute insulin deficiency; DKA prone; anti-GAD, anti-islet antibodies |
| Type 2 DM | Insulin resistance + relative deficiency | Most common; associated with obesity, metabolic syndrome |
| Insulinoma | Beta cell tumor | Fasting hypoglycemia, Whipple's triad |
| Glucagonoma | Alpha cell tumor | Necrolytic migratory erythema, diabetes, anemia |
| Zollinger-Ellison | Gastrinoma (delta-cell related) | Peptic ulcers, diarrhea |
| Hormone | Action |
|---|---|
| TRH | ↑TSH, ↑Prolactin |
| CRH | ↑ACTH |
| GHRH | ↑GH |
| Somatostatin (GHIH) | ↓GH, ↓TSH |
| GnRH | ↑FSH, ↑LH |
| Dopamine (PIH) | ↓Prolactin |
| Condition | Feature |
|---|---|
| Hypothalamic obesity | Lesions of ventromedial nucleus → hyperphagia |
| Central DI | ADH deficiency → polyuria |
| Kallmann Syndrome | GnRH deficiency + anosmia → hypogonadotropic hypogonadism |
| Froelich Syndrome | Hypothalamic lesion → obesity + hypogonadism |
| Central precocious puberty | Premature GnRH pulsatility |
| Hormone | Source | Actions |
|---|---|---|
| Estrogens (E2) | Granulosa cells (from androgens via aromatase) | Female sex characteristics, endometrial proliferation, LH surge (positive feedback), bone protection |
| Progesterone | Corpus luteum (after ovulation) | Endometrial secretory phase, maintains pregnancy, ↑basal body temperature |
| Inhibin | Granulosa cells | Inhibits FSH (negative feedback) |
| Activin | Granulosa cells | Stimulates FSH |
| AMH (anti-Müllerian hormone) | Granulosa cells of small follicles | Ovarian reserve marker |
| Disorder | Feature |
|---|---|
| PCOS (Polycystic Ovarian Syndrome) | ↑LH, ↑androgens, insulin resistance; oligomenorrhea, hirsutism, acne, infertility; multiple small cysts |
| Premature Ovarian Failure | Menopause <40 years; ↑FSH, ↓estrogen |
| Granulosa Cell Tumor | Estrogen-secreting; precocious puberty in girls, endometrial hyperplasia in adults; Call-Exner bodies |
| Turner Syndrome (45,X) | Ovarian dysgenesis → streak ovaries → primary amenorrhea, short stature, ↑FSH |
| Hormone | Source | Action |
|---|---|---|
| Testosterone | Leydig cells (LH stimulated) | Spermatogenesis (local), male secondary sex characteristics, anabolic effects, negative feedback on LH/FSH |
| DHT (dihydrotestosterone) | 5α-reductase converts T → DHT | External genitalia development, prostate growth, male pattern baldness |
| Inhibin | Sertoli cells | Inhibits FSH (selective feedback) |
| Estradiol | Sertoli cells (aromatase) | Bone development, spermatogenesis |
| AMH | Sertoli cells (fetal) | Regression of Müllerian (female) ducts |
| Disorder | Cause | Features |
|---|---|---|
| Klinefelter Syndrome (47, XXY) | Extra X chromosome | Hypogonadism, gynecomastia, tall stature, azoospermia, ↑FSH/LH, ↓testosterone, small testes |
| Cryptorchidism | Undescended testis | ↑Risk of seminoma, infertility |
| Hypogonadotropic Hypogonadism | Hypothalamic/pituitary failure | Low LH/FSH + low testosterone |
| Primary Hypogonadism | Testicular failure | Low testosterone, high LH/FSH |
| 5α-Reductase Deficiency | ↓DHT | 46,XY with ambiguous genitalia; virilization at puberty |
| Androgen Insensitivity Syndrome | AR mutation | 46,XY phenotypic female; absent uterus, testes in labia |
| Hormone | Action |
|---|---|
| Thymosin | Promotes T-cell differentiation and maturation |
| Thymulin | T-cell maturation, immunological functions |
| Thymopoietin | Promotes early T-cell development |
| Catecholamine | α1 | β1 | β2 | Key Effect |
|---|---|---|---|---|
| Epinephrine | ++ | ++ | +++ | ↑HR, ↑CO, bronchodilation, metabolic (↑glucose, lipolysis) |
| Norepinephrine | +++ | ++ | + | Mainly vasoconstriction, ↑BP |
| Cell Type | % | Hormone | Staining |
|---|---|---|---|
| Somatotrophs | 50% | GH | Acidophilic |
| Lactotrophs | 15-20% | Prolactin | Acidophilic |
| Corticotrophs | 15-20% | ACTH | Basophilic |
| Thyrotrophs | 5% | TSH | Basophilic |
| Gonadotrophs | 10% | FSH, LH | Basophilic |
| Disorder | Cause/Mechanism | Features |
|---|---|---|
| Acromegaly | GH-secreting adenoma (adults) | Frontal bossing, prognathism, ↑shoe/ring size, carpal tunnel, DM, hypertension; ↑IGF-1 is diagnostic test |
| Gigantism | GH excess in children (before epiphyseal closure) | Tall stature, can exceed 7 feet |
| Prolactinoma | Most common pituitary adenoma | Women: amenorrhea-galactorrhea; Men: impotence, gynecomastia. Treatment: Dopamine agonists (cabergoline, bromocriptine) |
| Nelson Syndrome | ACTH-secreting pituitary adenoma after bilateral adrenalectomy | Hyperpigmentation (ACTH/MSH), enlarging pituitary mass |
| Hypopituitarism | Mass effect, infarction, radiation | Deficiency of multiple hormones — GH first affected, then LH/FSH, then TSH/ACTH |
| Condition | Mechanism | Features |
|---|---|---|
| Central DI | ↓ADH synthesis/secretion | Polyuria (>3L/day), polydipsia, dilute urine (osmolality <200), responds to desmopressin |
| Nephrogenic DI | ADH resistance (V2 receptor mutation or lithium) | Same symptoms, does NOT respond to desmopressin |
| SIADH | Excess ADH | Euvolemic hyponatremia, concentrated urine, urine Na >20, causes: lung cancer (small cell), CNS disorders, drugs |
| Step | Process | Key Enzyme/Protein |
|---|---|---|
| 1 | Dietary iodide absorption → blood | — |
| 2 | Iodide uptake into follicular cell | NIS (Na⁺/I⁻ symporter) — inhibited by thiocyanate, perchlorate |
| 3 | Iodide transport to apical surface | Pendrin (apical transporter) — mutations → Pendred syndrome (goiter + deafness) |
| 4 | Oxidation of I⁻ to I⁰ or I₃⁻ | Thyroid Peroxidase (TPO) + H₂O₂ — blocked by PTU, methimazole |
| 5 | Organification of thyroglobulin (iodination of tyrosines → MIT, DIT) | TPO |
| 6 | Coupling: DIT+DIT → T4; DIT+MIT → T3 | TPO |
| 7 | Storage as colloid | Thyroglobulin in follicular lumen |
| 8 | Endocytosis of colloid (TSH-stimulated) | TSH → cAMP → endocytosis |
| 9 | Lysosomal hydrolysis → T3, T4 released | Proteases |
| 10 | MIT/DIT deiodinated (iodine recycled) | Dehalogenase (DEHAL1) |
| 11 | T4 → T3 peripherally (liver, kidney) | 5'-deiodinase (type 1, 2) |
| Pathology | Mechanism |
|---|---|
| Hypothyroidism | Hashimoto's, iodine deficiency, post-thyroidectomy, anti-thyroid drugs |
| Hyperthyroidism | Graves' (TSI), toxic nodule, excess iodine (Jod-Basedow), exogenous T4 |
| Goiter | ↑TSH drive due to iodine deficiency → gland hyperplasia |
| Thyroid Storm | Life-threatening thyrotoxicosis; fever, tachycardia, confusion; treat with PTU + beta-blockers + steroids + Lugol's |
| Hormone | Source | Effect on Ca²⁺ | Effect on PO₄³⁻ |
|---|---|---|---|
| PTH | Chief cells, parathyroid | ↑ | ↓ (phosphaturic) |
| Calcitriol (1,25-OH₂D₃) | Kidney (1α-hydroxylase, activated by PTH) | ↑ | ↑ |
| Calcitonin | C-cells, thyroid | ↓ | ↓ |
| Disease | Abnormality | Ca²⁺ | PTH | PO₄³⁻ |
|---|---|---|---|---|
| Primary Hyperparathyroidism | PTH adenoma | ↑ | ↑ | ↓ |
| Hypoparathyroidism | ↓PTH | ↓ | ↓ | ↑ |
| Pseudo-hypoparathyroidism | PTH resistance | ↓ | ↑ | ↑ |
| Vitamin D deficiency (Rickets/Osteomalacia) | ↓Calcitriol → ↓Ca²⁺ → 2° hyperPTH | ↓/normal | ↑(2°) | ↓ |
| Malignancy-associated hypercalcemia | PTHrP or osteolysis | ↑ | ↓ | ↑/normal |
| CRF (Secondary hyperPTH) | ↓Calcitriol, ↓Ca²⁺, ↑PO₄³⁻ | ↓ | ↑ | ↑ |
| Hormone | Effect on Glucose | Source | Stimulated By |
|---|---|---|---|
| Insulin | ↓ (hypoglycemic) | Beta cells | ↑Glucose, amino acids, GLP-1, GIP, vagus |
| Glucagon | ↑ (hyperglycemic) | Alpha cells | ↓Glucose, amino acids, epinephrine |
| Epinephrine | ↑ | Adrenal medulla | Stress, hypoglycemia |
| Cortisol | ↑ | Adrenal cortex (ZF) | ACTH |
| GH | ↑ (anti-insulin) | Anterior pituitary | GHRH, sleep, hypoglycemia |
| Glucocorticoids | ↑ | Adrenal cortex | ACTH |
| T3/T4 | Modulates | Thyroid | TSH |
| GLP-1 / GIP | ↓ (incretin effect) | L-cells/K-cells of gut | Meals |
| Disorder | Mechanism | Key Features |
|---|---|---|
| Type 1 DM | Autoimmune beta cell destruction | Absolute insulin deficiency; DKA (fruity breath, ↑anion gap, ↑ketones, ↑glucose) |
| Type 2 DM | Insulin resistance → relative deficiency | HHS (hyperosmolar hyperglycemic state); no ketones; ↑osmolality |
| Insulinoma | Excess insulin (tumor) | Fasting hypoglycemia; Whipple's triad: symptoms + low glucose + resolution with glucose |
| Glucagonoma | Excess glucagon | Hyperglycemia, necrolytic migratory erythema, weight loss |
| Cushing Syndrome | Excess cortisol → gluconeogenesis | Secondary/steroid DM |
| Acromegaly | Excess GH → insulin resistance | DM/glucose intolerance |
| Reactive Hypoglycemia | Exaggerated insulin response post-meal | Symptoms 2–4 hrs after eating |
| Gland | Key Hormone(s) | Key Disease |
|---|---|---|
| Adrenal Cortex | Cortisol, Aldosterone, DHEA | Cushing's, Addison's, Conn's |
| Adrenal Medulla | Epi, NE | Pheochromocytoma |
| Anterior Pituitary | GH, ACTH, TSH, FSH, LH, PRL | Acromegaly, Prolactinoma |
| Posterior Pituitary | ADH, Oxytocin | DI, SIADH |
| Thyroid | T3, T4, Calcitonin | Graves', Hashimoto's, CA |
| Parathyroid | PTH | Hyperparathyroidism, Tetany |
| Pancreas | Insulin, Glucagon | DM Type 1 & 2, Insulinoma |
| Hypothalamus | Releasing hormones | Kallmann, DI |
| Pineal | Melatonin | Circadian disorders |
| Ovaries | Estrogen, Progesterone | PCOS, Turner Syndrome |
| Testes | Testosterone, Inhibin | Klinefelter, Hypogonadism |
| Thymus | Thymosin | DiGeorge Syndrome |